{"database": "openregs", "table": "documents", "rows": [["FDA-2024-N-5331-0003", "FDA", "FDA-2024-N-5331", "Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Amendment of Notice\u2014Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement", "Notice", "Announcement", "2025-04-21T00:00:00Z", 2025, 4, "2025-04-21T00:00:00Z", "2025-05-05T03:59:59Z", "2025-05-13T09:00:48Z", "2025-06787", 0, 0, "0900006486aa4374"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2024-N-5331-0003"], "units": {}, "query_ms": 0.8281979244202375, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}